HUP1100470A2 - Nanoparticle-based veterinary vaccine - Google Patents

Nanoparticle-based veterinary vaccine

Info

Publication number
HUP1100470A2
HUP1100470A2 HU1100470A HUP1100470A HUP1100470A2 HU P1100470 A2 HUP1100470 A2 HU P1100470A2 HU 1100470 A HU1100470 A HU 1100470A HU P1100470 A HUP1100470 A HU P1100470A HU P1100470 A2 HUP1100470 A2 HU P1100470A2
Authority
HU
Hungary
Prior art keywords
nanoparticle
veterinary vaccine
based veterinary
vaccine
veterinary
Prior art date
Application number
HU1100470A
Other languages
Hungarian (hu)
Inventor
Ervin Dr Balazs
Akos Dr Gellert
Katalin Dr Salanki
Tamas Dr Tuboly
Original Assignee
Mezoegazdasagi Biotechnologiai Kutatokoezpont
Mta Agrartudomanyi Kutatokoezpont
Szent Istvan Egyetem
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mezoegazdasagi Biotechnologiai Kutatokoezpont, Mta Agrartudomanyi Kutatokoezpont, Szent Istvan Egyetem filed Critical Mezoegazdasagi Biotechnologiai Kutatokoezpont
Priority to HU1100470A priority Critical patent/HUP1100470A2/en
Priority to PCT/HU2012/000087 priority patent/WO2013030608A1/en
Publication of HUP1100470A2 publication Critical patent/HUP1100470A2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/14011—Bromoviridae
    • C12N2770/14041—Use of virus, viral particle or viral elements as a vector
HU1100470A 2011-08-30 2011-08-30 Nanoparticle-based veterinary vaccine HUP1100470A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
HU1100470A HUP1100470A2 (en) 2011-08-30 2011-08-30 Nanoparticle-based veterinary vaccine
PCT/HU2012/000087 WO2013030608A1 (en) 2011-08-30 2012-08-30 Nanoparticle-based veterinary vaccine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU1100470A HUP1100470A2 (en) 2011-08-30 2011-08-30 Nanoparticle-based veterinary vaccine

Publications (1)

Publication Number Publication Date
HUP1100470A2 true HUP1100470A2 (en) 2013-03-28

Family

ID=89990411

Family Applications (1)

Application Number Title Priority Date Filing Date
HU1100470A HUP1100470A2 (en) 2011-08-30 2011-08-30 Nanoparticle-based veterinary vaccine

Country Status (2)

Country Link
HU (1) HUP1100470A2 (en)
WO (1) WO2013030608A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA40824A (en) * 2014-10-22 2017-08-29 Saiba Gmbh MODIFIED VIRUS TYPE CMV PARTICLES
CN113301918A (en) * 2018-12-20 2021-08-24 塞坝股份公司 Virus-like particle modified by fusion of CMV
WO2024047091A2 (en) * 2022-08-30 2024-03-07 Saiba Animal Health Ag Veterinary compositions of modified virus-like particles of cmv and ngf antigens

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0429497B1 (en) * 1988-08-19 1993-10-06 The Upjohn Company Cocumber mosaic virus coat protein gene
FR2772047B1 (en) 1997-12-05 2004-04-09 Ct Nat D Etudes Veterinaires E GENOMIC SEQUENCE AND POLYPEPTIDES OF CIRCOVIRUS ASSOCIATED WITH PIGLET LOSS DISEASE (MAP), APPLICATIONS TO DIAGNOSIS AND TO PREVENTION AND / OR TREATMENT OF INFECTION
PT2363488E (en) * 1997-12-11 2015-01-13 Univ Belfast Postweaning multisystemic wasting syndrome virus from pigs
EP1290016A2 (en) * 2000-06-15 2003-03-12 Purdue Research Foundation Vaccine for congenital tremors in pigs
US7276353B2 (en) * 2001-12-12 2007-10-02 Virginia Tech Intellectual Properties, Inc. Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
TWI528970B (en) * 2005-12-29 2016-04-11 百靈佳殷格翰家畜藥品公司 Multivalent pcv2 immunogenic compositions and methods of producing such compositions
UA99495C2 (en) 2007-12-21 2012-08-27 Вайет Ллк Isolated hog circovirus, compositions and methods for hog immunization against hog circovirus
KR20100135903A (en) * 2008-04-16 2010-12-27 버지니아 테크 인터렉추얼 프라퍼티스, 인크. Chimeric porcine circovirus pcv2gen-1rep and uses thereof
KR20110090711A (en) * 2010-02-04 2011-08-10 녹십자수의약품(주) Novel porcine circovirus type 2 and use thereof

Also Published As

Publication number Publication date
WO2013030608A1 (en) 2013-03-07

Similar Documents

Publication Publication Date Title
HK1207967A1 (en) Vaccine
HK1212906A1 (en) Vaccine compositions
PL2647387T3 (en) Vaccine Composition
IL231043A (en) Vaccine
EP2876161A4 (en) Vaccine
GB201223386D0 (en) Vaccine
PT3275507T (en) Vaccine delivery method
EP2755680A4 (en) Particluate vaccine formulations
HK1212919A1 (en) Wt1 vaccine wt1
GB201119999D0 (en) Vaccine
EP2763699A4 (en) Vaccine
ZA201306245B (en) Combination vaccines
EP2771453A4 (en) Diatom-based vaccines
GB201014965D0 (en) Vaccine
HUP1100470A2 (en) Nanoparticle-based veterinary vaccine
GB201120000D0 (en) Vaccine
GB201013006D0 (en) Vaccine
GB201006324D0 (en) Vaccine
ZA201302154B (en) Vaccine
DK2846829T3 (en) Vaccine combinations
GB201121647D0 (en) Vaccine
GB201108256D0 (en) Vaccine
GB201217321D0 (en) Vaccine
GB201210226D0 (en) Vaccine
GB201206169D0 (en) Vaccine

Legal Events

Date Code Title Description
FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished
GB9A Succession in title

Owner name: MEZOEGAZDASAGI BIOTECHNOLOGIAI KUTATOKOEZPONT, HU

Free format text: FORMER OWNER(S): MTA MEZOEGAZDASAGI KUTATOINTEZET, HU; SZENT ISTVAN EGYETEM ALLATORVOS-TUDOMANYI KAR, HU

Owner name: SZENT ISTVAN EGYETEM, HU

Free format text: FORMER OWNER(S): MTA MEZOEGAZDASAGI KUTATOINTEZET, HU; SZENT ISTVAN EGYETEM ALLATORVOS-TUDOMANYI KAR, HU

Owner name: MAGYAR TUDOMANYOS AKADEMIA AGRARTUDOMANYI KUTA, HU

Free format text: FORMER OWNER(S): MTA MEZOEGAZDASAGI KUTATOINTEZET, HU; SZENT ISTVAN EGYETEM ALLATORVOS-TUDOMANYI KAR, HU